Toronto Dominion Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $29.7M | Sell |
38,427
-15,531
| -29% | -$11.9M | 0.04% | 328 |
|
|
2025
Q4 | $41.6M | Sell |
53,958
-938
| -2% | -$637K | 0.06% | 287 |
|
|
2025
Q3 | $30.9M | Sell |
54,896
-16,062
| -23% | -$9.08M | 0.05% | 324 |
|
|
2025
Q2 | $37.3M | Buy |
70,958
+21,790
| +44% | +$12.2M | 0.06% | 256 |
|
|
2025
Q1 | $31.2M | Sell |
49,168
-10,837
| -18% | -$7.45M | 0.06% | 241 |
|
|
2024
Q4 | $42.7M | Buy |
60,005
+5,286
| +10% | +$4.44M | 0.07% | 200 |
|
|
2024
Q3 | $57.5M | Buy |
54,719
+1,378
| +3% | +$1.53M | 0.1% | 142 |
|
|
2024
Q2 | $56.1M | Sell |
53,341
-8,879
| -14% | -$8.61M | 0.09% | 138 |
|
|
2024
Q1 | $59.9M | Buy |
62,220
+612
| +1% | +$582K | 0.09% | 146 |
|
|
2023
Q4 | $54.1M | Buy |
61,608
+1,892
| +3% | +$1.56M | 0.08% | 184 |
|
|
2023
Q3 | $49.1M | Sell |
59,716
-2,081
| -3% | -$1.64M | 0.08% | 190 |
|
|
2023
Q2 | $44.4M | Buy |
61,797
+2,190
| +4% | +$1.69M | 0.07% | 215 |
|
|
2023
Q1 | $49M | Buy |
59,607
+4,078
| +7% | +$3.08M | 0.08% | 184 |
|
|
2022
Q4 | $40M | Buy |
55,529
+8,217
| +17% | +$6.06M | 0.06% | 210 |
|
|
2022
Q3 | $32.6M | Sell |
47,312
-8,254
| -15% | -$5.19M | 0.06% | 218 |
|
|
2022
Q2 | $32.8M | Sell |
55,566
-7,889
| -12% | -$5.13M | 0.06% | 186 |
|
|
2022
Q1 | $44.3M | Sell |
63,455
-8,688
| -12% | -$5.5M | 0.07% | 160 |
|
|
2021
Q4 | $45.6M | Buy |
72,143
+14,694
| +26% | +$9.03M | 0.06% | 201 |
|
|
2021
Q3 | $34.8M | Buy |
57,449
+11,198
| +24% | +$6.95M | 0.05% | 193 |
|
|
2021
Q2 | $25.8M | Sell |
46,251
-5,316
| -10% | -$2.69M | 0.04% | 261 |
|
|
2021
Q1 | $24.4M | Sell |
51,567
-10,075
| -16% | -$4.91M | 0.04% | 239 |
|
|
2020
Q4 | $29.8M | Buy |
61,642
+3,072
| +5% | +$1.66M | 0.05% | 207 |
|
|
2020
Q3 | $32.8M | Sell |
58,570
-7,879
| -12% | -$4.78M | 0.08% | 157 |
|
|
2020
Q2 | $41.4M | Buy |
66,449
+5,748
| +9% | +$3.26M | 0.11% | 136 |
|
|
2020
Q1 | $29.6M | Sell |
60,701
-16,301
| -21% | -$6.72M | 0.09% | 168 |
|
|
2019
Q4 | $28.9M | Buy |
77,002
+15,989
| +26% | +$5.38M | 0.05% | 238 |
|
|
2019
Q3 | $16.9M | Sell |
61,013
-51,819
| -46% | -$15.3M | 0.04% | 333 |
|
|
2019
Q2 | $17.7M | Buy |
112,832
+57,873
| +105% | +$19.3M | 0.04% | 313 |
|
|
2019
Q1 | $22.6M | Buy |
54,959
+8,099
| +17% | +$3.34M | 0.04% | 282 |
|
|
2018
Q4 | $17.5M | Sell |
46,860
-3,945
| -8% | -$1.44M | 0.03% | 275 |
|
|
2018
Q3 | $20.5M | Buy |
50,805
+889
| +2% | +$338K | 0.04% | 275 |
|
|
2018
Q2 | $17.2M | Buy |
49,916
+8,157
| +20% | +$2.55M | 0.03% | 311 |
|
|
2018
Q1 | $14.4M | Buy |
41,759
+8,500
| +26% | +$2.96M | 0.03% | 317 |
|
|
2017
Q4 | $12.5M | Buy |
33,259
+4,057
| +14% | +$1.64M | 0.04% | 288 |
|
|
2017
Q3 | $13.1M | Buy |
29,202
+3,367
| +13% | +$1.6M | 0.04% | 242 |
|
|
2017
Q2 | $12.7M | Buy |
25,835
+5,295
| +26% | +$2.32M | 0.04% | 230 |
|
|
2017
Q1 | $7.96M | Buy |
20,540
+7,487
| +57% | +$2.78M | 0.02% | 294 |
|
|
2016
Q4 | $4.79M | Buy |
13,053
+10,832
| +488% | +$4.12M | 0.01% | 312 |
|
|
2016
Q3 | $893K | Buy |
2,221
+1,797
| +424% | +$721K | ﹤0.01% | 456 |
|
|
2016
Q2 | $148K | Sell |
424
-152
| -26% | -$58.5K | ﹤0.01% | 624 |
|
|
2016
Q1 | $208K | Sell |
576
-1,804
| -76% | -$743K | ﹤0.01% | 545 |
|
|
2015
Q4 | $1.29M | Sell |
2,380
-82
| -3% | -$44.4K | 0.01% | 310 |
|
|
2015
Q3 | $1.15M | Buy |
2,462
+382
| +18% | +$205K | 0.01% | 314 |
|
|
2015
Q2 | $1.06M | Buy |
2,080
+51
| +3% | +$24.9K | 0.01% | 381 |
|
|
2015
Q1 | $916K | Sell |
2,029
-1,033
| -34% | -$438K | ﹤0.01% | 386 |
|
|
2014
Q4 | $1.26M | Buy |
3,062
+1,669
| +120% | +$656K | 0.01% | 362 |
|
|
2014
Q3 | $502K | Sell |
1,393
-110
| -7% | -$36.9K | ﹤0.01% | 440 |
|
|
2014
Q2 | $425K | Buy |
1,503
+246
| +20% | +$72.9K | ﹤0.01% | 527 |
|
|
2014
Q1 | $377K | Buy |
1,257
+3
| +0.2% | +$924 | ﹤0.01% | 538 |
|
|
2013
Q4 | $345K | Buy |
+1,254
| New | +$361K | ﹤0.01% | 533 |
|
Other funds holding REGN
VCM
N
Toronto Dominion Bank's REGN Position: Q1 2026 in Review
Toronto Dominion Bank reduced its Regeneron Pharmaceuticals (REGN) stake by 29% in Q1 2026, selling an estimated $11.9M and leaving 38,427 shares worth $29.7M. The position accounts for 0.04% of the portfolio, ranked #328.
Toronto Dominion Bank first reported a position in REGN in Q4 2013 and has held it in 50 quarters since. The position peaked at $59.9M in Q1 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Toronto Dominion Bank held 38,427 shares of Regeneron Pharmaceuticals worth $29.7M as of Q1 2026.
- Toronto Dominion Bank sold 15,531 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $11.9M.
- Regeneron Pharmaceuticals made up 0.04% of Toronto Dominion Bank's portfolio in Q1 2026, its #328 holding.
- Toronto Dominion Bank first reported a position in Regeneron Pharmaceuticals in Q4 2013 and has held it in 50 quarters since.
- Toronto Dominion Bank's Regeneron Pharmaceuticals position peaked at $59.9M in Q1 2024.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.